Zacks.com on MSN9h
Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...
Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and ...
The National Kidney Foundation (NKF) is pleased to announce that Registered Dietitian, Brandon Kistler, PhD, RD, is the 2025 recipient of the Joel D. Kopple Distinguished Lecture ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, Seoul, with ...
We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...
Barchart on MSN14h
Job Growth Disappoints in January, Despite Lower UnemploymentJanuary's job growth fell short of expectations, according to the Bureau of Labor Statistics report released Friday. Only 143,000 nonfarm payrolls were added, a decrease from December's revised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback